Allergan, Valeant perfect match: CEO
Share

Allergan, Valeant perfect match: CEO

CNBC's David Faber and Jeffrey Ubben, ValueAct Capital Partners CEO, discuss Valeant Pharmaceuticals bid for Allergan and why Valeant needed investor Bill Ackman involved in the deal.
02:54
Tue, Apr 22 201410:48 AM EDT